Skip to main content
Previous Booth
Back to Exhibit
Next Booth

Booth Banner Image
Cara Therapeutics, Inc. Logo
  • Overview
  • Meet the Team
  • Website

Company Biography


Thank you Nephrology Nurses for your continued dedication to patients in the midst of the COVID-19 pandemic.



Chronic Kidney Disease associated Pruritus (CKD-aP)

  • Of over 500,000 patients undergoing dialysis in the US, more than 60% are affected by pruritus1-3
  • Of CKD-aP patients, 20% - 40% report it as moderate to severe2,4
  • CKD-aP is associated with adverse outcomes2


The pathophysiology of CKD-aP is not fully understood, but it is likely multifactorial. In addition to metabolic abnormalities, peripheral neuropathy, and xerosis, research has implicated a dysregulation of the immune system and the endogenous opioid system in the pathophysiology of CKD-aP.2,3,5,6


View the animation below to take a deeper look.




View the video below to hear from patients who have CKD-aP and the team that cares for them.



References

  1. National Kidney Foundation. About chronic kidney disease. https://www.kidney.org/atoz/content/about-chronic-kidney-disease. Accessed April 18, 2020.
  2. Ramakrishnan K, Bond TC, Claxton A, et al. Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis.2014;7:1-12.
  3. Mathur VS, Lindberg J, Germain M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410-1419.
  4. Rayner HC, Larkina M, Wang M, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000-2007.
  5. Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin Nephrol. 2015;35(4):383-391.
  6. Mettang T, Kremer AE. Uremic pruritus. Kidney Int. 2015;87(4):685-691.




Contact Information

Name
Josh Cirulli
Address
107 Elm Street, Suite 900
Stamford, CT 06902

You have chosen to not share your information with Cara Therapeutics, Inc.
Live chat

Team Members

Shelby  Oksman profile image

Shelby Oksman

Cara Therapeutics

Regional Director, MSLs
Shelby Oksman
Cara Therapeutics
Omaha, NE Phone: 475-214-3311
Email: soksman@caratherapeutics.com
Sherri  So profile image

Sherri So

Cara Therapeutics

Sr. Medical Science Liaison
Sherri So
Cara Therapeutics
Arlington, VA Phone: 203-391-3581
Email: sso@caratherapeutics.com
Jen  Mohawk profile image

Jen Mohawk

Cara Therapeutics

Sr. Medical Science Liaison
Jen Mohawk
Cara Therapeutics
Prosper, TX Phone: 434-996-8312
Email: jmohawk@caratherapeutics.com
Jill  Goode Englett profile image

Jill Goode Englett

Cara Therapeutics

Sr. Medical Science Liaison
Jill Goode Englett
Cara Therapeutics
Mesa, AZ Phone: 256-443-1894
Email: jenglett@caratherapeutics.com
Amina  Gangat profile image

Amina Gangat

Cara Therapeutics

Medical Science Liaison
Amina Gangat
Cara Therapeutics
New York, NY Phone: 718-669-0709
Email: agangat@caratherapeutics.com
Josh Cirulli, Pharm.D profile image

Josh Cirulli, Pharm.D

Cara Therapeutics

Senior Director, Medical Affairs and MSLs
Josh Cirulli, Pharm.D
Cara Therapeutics
Stamford, CT Phone: 610-698-3549
Email: jcirulli@caratherapeutics.com
Bill  Barrington profile image

Bill Barrington

Cara Therapeutics

Medical Science Liaison
Bill Barrington
Cara Therapeutics
Seattle, WA Phone: 919-827-5231
Email: wbarrington@caratherapeutics.com
Angela Ross profile image

Angela Ross

Cara Therapeutics

Medical Science Liaison
Angela Ross
Cara Therapeutics
Indianapolis, IN Phone: 317-217-0552
Email: aross@caratherapeutics.com